PropertyValue
?:definition
  • Immunoassay reagents intended to perform quantitative analyses on a body fluid sample (e.g., serum, urine) to measure levels of lidocaine (a local anesthetic and cardiac depressant typically used as an antiarrhythmia agent) present in the sample. These reagents are used in tests to monitor lidocaine drug levels in patients undergoine treatment to determine the adequacy of therapy and to diagnose drug overdose or drug-related toxicity.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3691472_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3691472_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all